Abstract |
Induction of specific immune response against therapy-resistant tumor cells can potentially improve clinical outcomes in malignancies. To optimize immunotherapy in the clinic, we aimed to create an in vivo model enabling us to analyze human cytotoxic T-lymphocyte (CTL) responses against human malignancies. To this end, we developed NOD/SCID/IL2rgKO (NSG) mice expressing the HLA class I molecules HLA-A*0201 and A*2402. In the bone marrow (BM) and spleen of HLA class I transgenic (Tg) NSG mice transplanted with cord blood hematopoietic stem cells (HSCs), we found human memory CD8(+) T cells and antigen-presenting cells. To evaluate antigen-specific human CTL responses, we immunized HLA class I Tg NSG mice using polyinosinic:polycytidylic acid mixed Wilms tumor 1 (WT1) peptides, with or without WT1 peptide-loaded autologous dendritic cells. After immunization, the frequencies of HLA-restricted WT1-specific CTLs increased significantly in the spleen. Next, we transplanted the WT1-specific T-cell receptor (WT1-TCR) gene-transduced human HSCs into HLA class I Tg NSG newborn mice. WT1 tetramer-positive CD8(+) T cells differentiated from WT1-TCR-transduced HSCs in the recipients' BM, spleen, and thymus. Upon stimulation with WT1 peptide in vitro, these CTLs produced interferon-γ and showed lytic activity against leukemia cells in an antigen-specific, HLA-restricted manner. HLA class I Tg NSG xenografts may serve as a preclinical model to develop effective immunotherapy against human malignancies.
|
Authors | Yuho Najima, Mariko Tomizawa-Murasawa, Yoriko Saito, Takashi Watanabe, Rintaro Ono, Toshiki Ochi, Nahoko Suzuki, Hiroshi Fujiwara, Osamu Ohara, Leonard D Shultz, Masaki Yasukawa, Fumihiko Ishikawa |
Journal | Blood
(Blood)
Vol. 127
Issue 6
Pg. 722-34
(Feb 11 2016)
ISSN: 1528-0020 [Electronic] United States |
PMID | 26702062
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Copyright | © 2016 by The American Society of Hematology. |
Chemical References |
- HLA-A*02:01 antigen
- HLA-A*24:02 antigen
- HLA-A2 Antigen
- HLA-A24 Antigen
- Il2rg protein, mouse
- Interleukin Receptor Common gamma Subunit
- WT1 Proteins
- WT1 protein, human
|
Topics |
- Animals
- Animals, Newborn
- CD8-Positive T-Lymphocytes
(metabolism, physiology)
- Cell Differentiation
(genetics, immunology)
- Cells, Cultured
- Female
- HLA-A2 Antigen
(genetics, metabolism)
- HLA-A24 Antigen
(genetics, metabolism)
- Hematopoietic Stem Cells
(physiology)
- Humans
- Interleukin Receptor Common gamma Subunit
(genetics)
- K562 Cells
- Mice
- Mice, Inbred NOD
- Mice, SCID
- Mice, Transgenic
- T-Lymphocytes, Cytotoxic
(immunology, metabolism)
- WT1 Proteins
(metabolism)
|